Aspira Women's Health Files 8-K on Shareholder Vote Matters

Ticker: AWHL · Form: 8-K · Filed: Jun 4, 2025 · CIK: 926617

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: AWH

TL;DR

Aspira Women's Health (AWH) filed an 8-K on June 4th about shareholder votes - watch for updates.

AI Summary

Aspira Women's Health Inc. filed an 8-K on June 4, 2025, reporting on matters submitted to a vote of its security holders. The filing details corporate actions and governance, with the company previously known as Vermillion, Inc. and Ciphergen Biosystems Inc.

Why It Matters

This filing indicates important corporate decisions are being made that could affect shareholder rights and the company's strategic direction.

Risk Assessment

Risk Level: medium — Filings related to shareholder votes can signal significant corporate events or changes that may impact stock price.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Aspira Women's Health Inc. security holders?

The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text excerpt.

When was this 8-K report filed?

This 8-K report was filed on June 4, 2025.

What is the primary business of Aspira Women's Health Inc.?

Aspira Women's Health Inc. is involved in 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.

What were some previous names of Aspira Women's Health Inc.?

Aspira Women's Health Inc. was formerly known as Vermillion, Inc. and Ciphergen Biosystems Inc.

Where is Aspira Women's Health Inc. headquartered?

Aspira Women's Health Inc. is headquartered in Austin, Texas, with its business address at 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Aspira Women's Health Inc. (AWHL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing